Amanote Research
Register
Sign In
Use of Surrogate Outcomes in Health Technology Assessments (HTAs)
Value in Health
- United Kingdom
doi 10.1016/j.jval.2013.08.1771
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
November 1, 2013
Authors
A. Jaksa
Y.S. Ho
K. Daniel
Publisher
Elsevier BV
Related search
Do Patient Reported Outcomes (Pro) in Oncology Matter in Health Technology Assessments (Hta)?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PCN151 HTAs for the Deadliest Diseases: What Can We Learn From Multi-National Comparisons of Oncology and Cardiology Health Technology Assessments?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Modeling Treatment Sequences in Health Technology Assessments
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PHP167 the Role of Decision-Analytic Modeling in German Health Technology Assessments
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Review of Health Technology Assessments (HTA) of PCSK9 Inhibitors (PSCK9I)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn314 - Health-Technology Assessments in Oncology: Results of a Review of Decisions in Germany
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Balancing Evidence and Public Opinion in Health Technology Assessments: The Case of Leukoreduction
International Journal of Technology Assessment in Health Care
Health Policy
Php291 - Shaping the Future of European Health Technology Assessments: Experiences of Three Pharmaceutical Joint Rapid Relative Effectiveness Assessments
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Use of Information Technology in Healthcare Sector for Improving Outcomes
International Journal of Basic & Clinical Pharmacology
